The expression and clinical significance of different forms of Mer receptor tyrosine kinase in systemic lupus erythematosus

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Zhu, Huaqun ^a   Sun, Xiaolin ^a   Zhu, Lei ^a   Hu, Fanlei ^a   Shi, Lianjie ^a   Li, Zhanguo ^a   Su, Yin ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; MESSENGER RNA; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE MER; RO ANTIBODY; SM ANTIBODY; UNCLASSIFIED DRUG; ADAM PROTEIN; MERTK PROTEIN, HUMAN; ONCOPROTEIN; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; BLOOD; CASE CONTROL STUDY; GENE EXPRESSION; GENETICS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADAM PROTEINS; ADULT; ANTIGENS, CD14; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84897557376     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/431896     Document Type: Article

References (35)

1. Verma A., Warner S. L., Vankayalapati H., Bearss D. J., Sharma S., Targeting Axl and Mer kinases in cancer. Molecular Cancer Therapeutics 2011 10 10 1763 1773 2-s2.0-80053944035 10.1158/1535-7163.MCT-11-0116
2. Graham D. K., Dawson T. L., Mullaney D. L., Snodgrass H. R., Earp H. S., Cloning and mRNA expression analysis of a novel human protooncogene, c- mer. Cell Growth and Differentiation 1994 5 6 647 657 2-s2.0-0028085513 (Pubitemid 24252329)
3. Hafizi S., Dahlbäck B., Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases. Cytokine and Growth Factor Reviews 2006 17 4 295 304 2-s2.0-33745814436 10.1016/j.cytogfr.2006.04.004 (Pubitemid 44038616)
4. Linger R. M. A., Keating A. K., Earp H. S., Graham D. K., TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Advances in Cancer Research 2008 100 35 83 2-s2.0-46449103344 10.1016/S0065-230X(08)00002-X (Pubitemid 351932179)
5. Garbin U., Baggio E., Stranieri C., Pasini A., Manfro S., Mozzini C., Vallerio P., Lipari G., Merigo F., Guidi G., Cominacini L., Fratta Pasini A., Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids? Cardiovascular Research 2013 97 1 125 133 10.1093/cvr/cvs301
6. Thorp E., Vaisar T., Subramanian M., Mautner L., Blobel C., Tabas I., Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase C δ and p38 Mitogen-activated Protein Kinase (MAPK). The Journal of Biological Chemistry 2011 286 38 33335 33344 2-s2.0-80053030745 10.1074/jbc.M111.263020
7. Sather S., Kenyon K. D., Lefkowitz J. B., Liang X., Varnum B. C., Henson P. M., Graham D. K., A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 2007 109 3 1026 1033 2-s2.0-33846872571 10.1182/blood-2006-05-021634 (Pubitemid 46220648)
8. Scott R. S., McMahon E. J., Pop S. M., Reap E. A., Caricchio R., Cohen P. L., Earp H. S., Matsushima G. K., Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001 411 6834 207 211 2-s2.0-0035837323 10.1038/35075603 (Pubitemid 32455181)
9. Seitz H. M., Camenisch T. D., Lemke G., Earp H. S., Matsushima G. K., Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. The Journal of Immunology 2007 178 9 5635 5642 2-s2.0-34247580796 (Pubitemid 46674359)
10. Lemke G., Burstyn-Cohen T., TAM receptors and the clearance of apoptotic cells. Annals of the New York Academy of Sciences 2010 1209 1 23 29 2-s2.0-78049499991 10.1111/j.1749-6632.2010.05744.x
11. Camenisch T. D., Koller B. H., Earp H. S., Matsushima G. K., A novel receptor tyrosine kinase, mer, inhibits TNF- α production and lipopolysaccharide-induced endotoxic shock. The Journal of Immunology 1999 162 6 3498 3503 2-s2.0-0033559140 (Pubitemid 29313601)
12. Rothlin C. V., Ghosh S., Zuniga E. I., Oldstone M. B. A., Lemke G., TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007 131 6 1124 1136 2-s2.0-36849033963 10.1016/j.cell.2007.10.034 (Pubitemid 350235020)
13. Rahman Z. S. M., Shao W.-H., Khan T. N., Zhen Y., Cohen P. L., Impaired apoptotic cell clearance in the Germinal center by Mer-deficient tingible body macrophages leads to enhanced antibody-forming cell and Germinal center responses. The Journal of Immunology 2010 185 10 5859 5868 2-s2.0-78650648219 10.4049/jimmunol.1001187
14. Wallet M. A., Sen P., Flores R. R., Wang Y., Yi Z., Huang Y., Mathews C. E., Earp H. S., Matsushima G., Wang B., Tisch R., MerTK is required for apoptotic cell-induced T cell tolerance. Journal of Experimental Medicine 2008 205 1 219 232 2-s2.0-38749108510 10.1084/jem.20062293 (Pubitemid 351185728)
15. Shao W.-H., Eisenberg R. A., Cohen P. L., The Mer receptor tyrosine kinase is required for the loss of B cell tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus. The Journal of Immunology 2008 180 11 7728 7735 2-s2.0-47249136911
16. Shao W.-H., Kuan A. P., Wang C., Abraham V., Waldman M. A., Vogelgesang A., Wittenburg G., Choudhury A., Tsao P. Y., Miwa T., Eisenberg R. A., Cohen P. L., Disrupted Mer receptor tyrosine kinase expression leads to enhanced MZ B-cell responses. Journal of Autoimmunity 2010 35 4 368 374 2-s2.0-77958151890 10.1016/j.jaut.2010.08.001
17. Ye F., Han L., Lu Q., Dong W., Chen Z., Shao H., Kaplan H. J., Li Q., Lu Q., Retinal self-antigen induces a predominantly Th1 effector response in Axl and Mertk double-knockout mice. The Journal of Immunology 2011 187 8 4178 4186 2-s2.0-80054759357 10.4049/jimmunol.1101201
18. Khan T. N., Wong E. B., Soni C., Rahman Z. S., Prolonged apoptotic cell accumulation in Germinal centers of Mer-deficient mice causes elevated B cell and CD4+ Th cell responses leading to autoantibody production. The Journal of Immunology 2013 190 4 1433 1446
19. Rothlin C. V., Lemke G., TAM receptor signaling and autoimmune disease. Current Opinion in Immunology 2010 22 6 740 746 2-s2.0-78649848107 10.1016/j.coi.2010.10.001
20. Choi J., Kim S. T., Craft J., The pathogenesis of systemic lupus erythematosus-an update. Current Opinion in Immunology 2012 24 6 651 657
21. Gaipl U. S., Munoz L. E., Grossmayer G., Lauber K., Franz S., Sarter K., Voll R. E., Winkler T., Kuhn A., Kalden J., Kern P., Herrmann M., Clearance deficiency and systemic lupus erythematosus (SLE). Journal of Autoimmunity 2007 28 2-3 114 121 2-s2.0-34247590859 10.1016/j.jaut.2007.02.005 (Pubitemid 46680499)
22. Muñoz L. E., Lauber K., Schiller M., Manfredi A. A., Herrmann M., The role of defective clearance of apoptotic cells in systemic autoimmunity. Nature Reviews Rheumatology 2010 6 5 280 289 2-s2.0-77951971046 10.1038/nrrheum.2010.46
23. Lu Q., Lemke G., Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 2001 293 5528 306 311 2-s2.0-0035854442 10.1126/science.1061663 (Pubitemid 32694748)
24. Cohen P. L., Caricchio R., Abraham V., Camenisch T. D., Jennette J. C., Roubey R. A. S., Earp H. S., Matsushima G., Reap E. A., Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. Journal of Experimental Medicine 2002 196 1 135 140 2-s2.0-0036645294 10.1084/jem.20012094 (Pubitemid 34747319)
25. Suh C.-H., Hilliard B., Li S., Merrill J. T., Cohen P. L., TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Research and Therapy 2010 12 4, article R146 2-s2.0-77954554268 10.1186/ar3088
26. Wu J., Ekman C., Jönsen A., Sturfelt G., Bengtsson A. A., Gottsäter A., Lindblad B., Lindqvist E., Saxne T., Dahlbäck B., Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosusrelate to disease activity and nephritis. Arthritis Research and Therapy 2011 13 2, article R62 10.1186/ar3316
27. Cairns A. P., Crockard A. D., Bell A. L., The CD14+ CD16+ monocyte subset in rheumatoid arthritis and systemic lupus erythematosus. Rheumatology International 2002 21 5 189 192 2-s2.0-0036192966 10.1007/s00296-001-0165-8 (Pubitemid 34209119)
28. Zizzo G., Hilliard B. A., Monestier M., Cohen P. L., Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. The Journal of Immunology 2012 189 7 3508 3520 10.4049/jimmunol.1200662
29. McColl A., Bournazos S., Franz S., Perretti M., Morgan B. P., Haslett C., Dransfield I., Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. The Journal of Immunology 2009 183 3 2167 2175 2-s2.0-68149164365 10.4049/jimmunol.0803503
30. Petri M., Orbai A. M., Alarcón G. S., Gordon C., Merrill J. T., Fortin P. R., Bruce I. N., Isenberg D., Wallace D. J., Nived O., Sturfelt G., Ramsey-Goldman R., Bae S. C., Hanly J. G., Sa'nchez-Guerrero J., Clarke A., Aranow C., Manzi S., Urowitz M., Gladman D., Kalunian K., Costner M., Werth V. P., Zoma A., Bernatsky S., Ruiz-Irastorza G., Khamashta M. A., Jacobsen S., Buyon J. P., Maddison P., Dooley M. A., van Vollenhoven R. F., Ginzler E., Stoll T., Peschken C., Jorizzo J. L., Callen J. P., Lim S. S., Fessler B. J., Inanc M., Kamen D. L., Rahman A., Steinsson K., Franks A. G. Jr., Sigler L., Hameed S., Fang H., Pham N., Brey R., Weisman M. H., McGwin G. Jr., Magder L. S., Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis and Rheumatism 2012 64 8 2677 2686 10.1002/art.34473
31. Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H., Derivation of the SLEDAI: a disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis and Rheumatism 1992 35 6 630 640 2-s2.0-0026777352
32. O'Neill L. A. J., TAMpering with Toll-like receptor signaling. Cell 2007 131 6 1039 1041 2-s2.0-36849017477 10.1016/j.cell.2007.11.032 (Pubitemid 350235032)
33. Shao W.-H., Zhen Y., Rosenbaum J., Eisenberg R. A., McGaha T. L., Birkenbach M., Cohen P. L., A protective role of Mer receptor tyrosine kinase in nephrotoxic serum-induced nephritis. Clinical Immunology 2010 136 2 236 244 2-s2.0-77954309871 10.1016/j.clim.2010.04.002
34. Recarte-Pelz P., Tàssies D., Espinosa G., Hurtado B., Sala N., Cervera R., Reverter J. C., de Frutos P. G., Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity. Arthritis Research and Therapy 2013 15 2, article R41 10.1186/ar4199
35. Zizzo G., Cohen P. L., IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids. The Journal of Immunology 2013 190 10 5237 5246 10.4049/jimmunol.1203017